CEL-SCI Corporation, a clinical-stage biotechnology company, engages in the research and development to treat cancer and other diseases by using the immune system in the United States. The company's lead immunotherapy is Multikine, which ha...
Q2 2026
May 15, 2026
Q1 2026
Feb 17, 2026
FY 2025
Dec 29, 2025
Q4 2025
Q3 2025
Aug 14, 2025